Clinical Trials Browser

Retinoblastoma × Anti-Infective Agents × Clear all

NCT02792036 2020-02-20

Intravitreal Carboplatin for the Treatment of Participants With Recurrent or Refractory Intraocular Retinoblastoma

Phase 1 Completed

Other solid neoplasm

Retinoblastoma